Skip to main content

Table 1 General patient characteristics with data presentation and statistical analysis depending on WHO grades of a meningioma. Note the statistically significant difference in the patients’ HbA1c between patients with different meningioma grades. Note also that grade 2 meningiomas had a higher expression of Ki67 reactivity, indicating that they exhibited more cellular proliferation

From: Chronic hyperglycemia and intracranial meningiomas

Characteristics

All patients (N = 71)

WHO grade 1 (N = 53)

WHO grade 2 (N = 18)

P (Mann-Whitney)

1. Age*

63 (36-84)

63 63 (36-84)

64 (48-80)

0.7862

2. BMI**

27.4 (24.6–30.0)

28.2 (24.6–30.1)

27.0 (24.6–29.7)

0.7361

Variables

1. HbA1c (%)**

5.8 (5.6–6.1)

5.8 (5.6–6.0)

6.1 (5.7–6.4)

0.0290

2. Ki67 (%)**

6.0 (3.0–14.8)

5.0 (2.0–10.5)

13.5 (7.0–20.0)

0.0001

  1. BMI– body mass index; * median and whole range; ** median and interquartile range